Carolina Arenas, DVM, PhD, DECVIM: No relevant disclosure to display
The audience will be provided with the most recent up to date and evidence-based information on monitoring methods for trilostane treatment. I will try expose the difficulties that arise when monitoring dogs on treatment with trilostane with the available monitoring methods and why the clinical picture is so important.
Learning Objectives:
To understand the difficulties in monitoring trilostane treatmet with the current available tools
Understand the importance of a good clinical history and physical examination in the assessment of canine hyperadrenocorticism
